Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1994-01-19
1997-10-28
Housel, James C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4242411, 4242751, 4242821, 424810, 514885, 530868, A61K 3902, A61K 39108, A61K 39106
Patent
active
056815719
ABSTRACT:
An immunological tolerance-inducing agent comprising a mucosa-binding molecule linked to a specific tolerogen is disclosed. Further, a method of inducing immunological tolerance in an individual against a specific antigen, including hapten, which causes an unwanted immune response in said individual comprising administration by a mucosal route of an immunologically effective amount of an immunological tolerance-inducing agent of the invention to said individual, is described.
REFERENCES:
Theof.lopoulos A.N. "Autoimmunity" in Basic & Clinical Immunology 6th ed. Stites et al eds, Appleton & Lange, Norwalk CT. 1987, pp. 128-158.
Ernst et al, "Immunity in Mucusal Tissues" in Basic & Clinical Immunology 6th ed, Stites et al eds, Appleton & Lange, Norwalk CT. 1987, pp. 159-166.
Dertzbaugh et al, Infect. Immun 61(2):384-390, 1993.
Bianchi et al Reg. Immunology 3(3):131-138, 1990.
Raine CS. "Experimental allergic encephalomyelitis and experimental allergic neuritis" in Handbook of Clinical Neurology vol. 3(47) Demylenating Diseases Koetsier et al eds. Elsevier Science Publishers, 1985 pp. 429-466.
Alvord et al, Annals of Neurology 6(6): 461-468, 1979.
Ruitt et al Immunology Gowen Medical Publishing London 1985 p, 19.1.
Weiner, H.L., Treatment of Autoimunune Diseases By Oral Tolerance, Mucosal Immunology Update (Fall, 1993), pp. 1-16.
Weiner, H.L., Friedman, A., Miller, A. Khoury, S.J., Al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R.B., Trentham, D.E., Hafler, D.A., Oral Tolerance: Immunologic mechanisms and treatment of murine and human organ specific autoimmune diseases by oral administration of autoantigens, Ann. Rev. Immunol., OT Rev. Aug. 17, 1993, 3:53 PM, pp. 1-45, 3 sheet of Figures (FIGS. 1-3).
Mcl. Mowat, A., The regulation of immune responses to dietary protein antigens, Immunology Today, vol. 8, No. 3, 1987, pp. 93-98.
Thompson, H.S.G. and Staines, N.A., Could specific and tolerance be a therapy for autoimmune disease?, Immunology Today, vol. 11, No. 11, 1990, pp. 396-399.
Czerkinsky, C., Russell, M.W., Lycke, N., Lindblad, M., and Holmgren, J., Oral Administration of a Streptococcal Antigen Coupled to Cholera Toxin B Subunit Evokes Strong Antibody Responses in Salivary Glands and Extramucosal Tissues, Infection and Immunity, vol. 57, No. 4, Apr. 1989, pp. 1072-1077.
DeAizpurua, H.J., and Russell-Jones, G.J., Oral Vaccination: Identification of Classes of Proteins that Provoke an Immune Response upon Oral Feeding, From the Immunochemistry Laboratory, Biotechnology Australia Pty. Ltd., Sydney, Australia, J. Exp. Med., The Rockefeller University Press, vol. 167, Feb. 1988, pp. 440-451.1.
Vives, J., Parks, D.E., and Weigle, W.O., Immunologic Unresponsiveness After Gastric Administration of Human .gamma.-Globulin: Antigen Requirements and Cellular Parameters, From the Department of Immunopathology, Scripps Clinic and research Foundation, La Jolla, CA, The Journal of Immunology, vol. 125, No. 4, Oct. 1980, pp. 1811-1816.
Zhang, Z.J., Lee, C.S.Y., Lider, O., and Weiner, H.L., Suppression Of Adjuvant Arthritis In Lewis Rats By Oral Administration Of Type II Collagen, From the Center for Neurologic Diseases, Division of Neurology, Department of Medicine, Brigham & Women's Hospital, Harvard Medical School, Boston, MA 02115, The Journal of Immunology, vol. 145, No. 8, Oct. 15, 1990, pp. 2489-2493.
Nedrud, J.G., Liang, X., Hague, N., and Lamm, M.E., Combined Oral/Nasal Immunication Protects Mice From Sendai Virus Infection, From the Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106, The Journal of Immunology, vol. 139, No. 10, Nov. 15, 1987, pp. 3484-3492.
McKenzie, S.J., and Halsey, J.F., Cholera Toxin B Subunit As A Carrier Protein To Stimulate A Mucosal Immune Response, From the Department of Biochemistry, University of Kansas College of Health Sciences and Hospital, Kansas City, KS 66103, The Journal of Immunology, vol. 133, No. 4, Oct. 1984, pp. 1818-1824.
Elson, C.O., and Ealding, W., Cholera Toxin Feeding Did OT Induce Oral Tolerance In Mice And Abrogated Oral Tolerance To An Unrelated Protein Antigen, From the Department of Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond VA, The Journal of Immunology, vol. 133, No. 6, Dec. 1984, pp. 2892-2897.
Elson et al, J. Immunol 133(6):2892-2897, 1984.
Clements et al, Vaccine 6:269-277, 1988.
Romaghahi et al, Int. Arch. Allergy Immunol 98:279-285 1992.
Spangler-BD, Microbiological Reviews, 56(4): 622-647, 1992.
Sell S. Immunology Immunopathology & Immunity 4th ed. Elsevier, N.Y. 1987 pp. 272-274 & 285-293.
Czerkinsky Cecil
Holmgren Jan
Duotol AB
Housel James C.
Swartz Rodney P.
LandOfFree
Immunological tolerance-inducing agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunological tolerance-inducing agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunological tolerance-inducing agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1024311